X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (25) 25
neur6 (25) 25
neur1 (22) 22
original reports (21) 21
life sciences & biomedicine (20) 20
oncology (20) 20
science & technology (20) 20
female (19) 19
male (18) 18
adult (17) 17
middle aged (17) 17
aged (15) 15
brain neoplasms - drug therapy (14) 14
disease-free survival (12) 12
glioblastoma - drug therapy (11) 11
neur5 (11) 11
treatment outcome (11) 11
brain neoplasms - mortality (10) 10
neur7 (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
dacarbazine - analogs & derivatives (9) 9
dacarbazine - administration & dosage (7) 7
young adult (7) 7
glioblastoma - mortality (6) 6
kaplan-meier estimate (6) 6
adolescent (5) 5
brain neoplasms - pathology (5) 5
brain neoplasms - radiotherapy (5) 5
glioma - drug therapy (5) 5
lomustine - administration & dosage (5) 5
neur8 (5) 5
prognosis (5) 5
to22 (5) 5
antineoplastic agents - therapeutic use (4) 4
antineoplastic agents, alkylating - administration & dosage (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
bios3 (4) 4
central nervous system neoplasms - drug therapy (4) 4
chemoradiotherapy (4) 4
glioblastoma - radiotherapy (4) 4
glioma - mortality (4) 4
neoplasm recurrence, local - drug therapy (4) 4
neur4 (4) 4
procarbazine - administration & dosage (4) 4
to1 (4) 4
vincristine - administration & dosage (4) 4
aged, 80 and over (3) 3
antineoplastic agents - adverse effects (3) 3
antineoplastic agents, alkylating - therapeutic use (3) 3
chemotherapy, adjuvant (3) 3
child (3) 3
dacarbazine - adverse effects (3) 3
dacarbazine - therapeutic use (3) 3
disease progression (3) 3
drug administration schedule (3) 3
glioblastoma - pathology (3) 3
magnetic resonance imaging (3) 3
methotrexate - administration & dosage (3) 3
multivariate analysis (3) 3
proportional hazards models (3) 3
quinazolines - administration & dosage (3) 3
radiotherapy, adjuvant (3) 3
recurrence (3) 3
risk factors (3) 3
survival analysis (3) 3
time factors (3) 3
to2 (3) 3
610 medicine & health (2) 2
angiogenesis inhibitors - therapeutic use (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents - pharmacokinetics (2) 2
bevacizumab (2) 2
brain neoplasms - diagnosis (2) 2
brain neoplasms - enzymology (2) 2
brain neoplasms - genetics (2) 2
brain neoplasms - surgery (2) 2
brain neoplasms - therapy (2) 2
brain tumors (2) 2
central nervous system neoplasms - diagnosis (2) 2
chemoradiotherapy, adjuvant (2) 2
chi-square distribution (2) 2
child, preschool (2) 2
clinic for neurology (2) 2
clinical trials (2) 2
clinical trials as topic (2) 2
clinical trials, phase iii as topic (2) 2
combined modality therapy (2) 2
glioblastoma - surgery (2) 2
glioblastoma multiforme (2) 2
glioma (2) 2
glioma - pathology (2) 2
glioma - radiotherapy (2) 2
glioma - therapy (2) 2
hema13 (2) 2
isocitrate dehydrogenase - genetics (2) 2
maximum tolerated dose (2) 2
mutation (2) 2
neoplasm grading (2) 2
neoplasm recurrence, local - mortality (2) 2
patient selection (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of clinical oncology, ISSN 1527-7755, 06/2010, Volume 28, Issue 17, pp. 2817 - 2823
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article